Multidrug Resistance in a Urothelial Cancer Cell Line After 1-Hour Mitomycin C Exposure

Journal of Urology

Volumn 182, Issue 5, 2009, Pages 2472-2476

  Birare, Narendrakumar ^a   Lwaleed, Bashir A ^a   Cooper, Alan J ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

carcinoma; drug resistance; mitomycin; multiple; transitional cell; urinary bladder; urothelium

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; EPIRUBICIN; MITOMYCIN C; ANTINEOPLASTIC ANTIBIOTIC; MITOMYCIN;

ARTICLE; CANCER CELL CULTURE; CELL CLONE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR; BLADDER TUMOR; DRUG RESISTANCE; TIME; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; HUMANS; MITOMYCIN; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 70350445179     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.007     Document Type: Article

References (19)

1. Tolley D.A., Parmar M.K., Grigor K.M., et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol 155 (1996) 1233
2. Inaba M., Kobayashi H., Sakurai Y., et al. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukaemia. Cancer Res 39 (1979) 2200
3. McGovern F., Kachel T., Vijan S., et al. Establishment and characterization of a doxorubicin-resistant human bladder cancer cell line (MGH-U1R). J Urol 140 (1988) 410
4. Coley H.M., Twentyman P.R., and Workman P. The efflux of anthracyclines in multidrugresistant cell lines. Biochem Pharmacol 46 (1993) 1317
5. Speers A.G., Lwaleed B.A., Featherstone J.M., et al. Multidrug resistance in a urothelial cancer cell line after 3, 1-hour exposures to mitomycin C. J Urol 178 (2007) 2171
6. Masters J.R., Popert R.J., Thompson P.M., et al. Intravesical chemotherapy with epirubicin: a dose response study. J Urol 161 (1999) 1490
7. Weaver J.L., Szabo Jr. G., Pine P.S., et al. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter. Int J Cancer 54 (1993) 456
8. Duffy P.M., Hayes M.C., Cooper A., et al. Determination and reversal of resistance to epirubicin intravesical chemotherapy. A flow cytometric model. Br J Urol 77 (1996) 819
9. Jennings A.M., Solomon L.Z., Sharpe P., et al. Estramustine reversal of resistance to intravesical epirubicin chemotherapy. Eur Urol 35 (1999) 327
10. Ibrahim S., Peggins J., Knapton A., et al. Influence of beta-adrenergic antagonists, H1-receptor blockers, analgesics, diuretics, and quinolone antibiotics on the cellular accumulation of the anticancer drug, daunorubicin: P-glycoprotein modulation. Anticancer Res 21 (2001) 847
11. Lewin J., Cooper A., and Birch B. Progesterone: a novel adjunct to intravesical chemotherapy. BJU Int 90 (2002) 736
12. Speers A.G., Lwaleed B.A., Featherstone J.M., et al. Furosemide reverses multidrug resistance status in bladder cancer cells in vitro. J Clin Pathol 59 (2006) 912
13. Lukkarinen O., Paul C., Hellström P., et al. Intravesical epirubicin with and without verapamil for the prophylaxis of superficial bladder tumours. Scand J Urol Nephrol 25 (1991) 25
14. Naito S., Kotoh S., Omoto T., et al. Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group. Cancer Chemother Pharmacol 42 (1998) 367
15. Tsushima T., Ohmori H., Ohi Y., et al. Intravesical instillation chemotherapy of adriamycin with or without verapamil for the treatment of superficial bladder cancer: the final results of a collaborative randomized trial. Cancer Chemother Pharmacol 35 (1994) 69
16. Gottesman M.M., and Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62 (1993) 385
17. Featherstone J.M., Speers A.G., Lwaleed B.A., et al. The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines. BJU Int 95 (2005) 1091
18. Duffy P.M., Hayes M.C., Cooper A., et al. Confocal microscopy of idarubicin localisation in sensitive and multidrug-resistant bladder cancer cell lines. Br J Cancer 74 (1996) 906
19. Bobichon H., Cailleret L., Ploton D., et al. Nuclear transport as an ultimate step of multidrug resistance. Life Sci 65 (1999) 2343